Cell tracking using multimodal imaging

Contrast Media and Molecular Imaging

Volumn 8, Issue 6, 2013, Pages 432-438

  Srinivas, Mangala ^a   Melero, Ignacio ^b   Kaempgen, Eckhart ^c   Figdor, Carl G ^a   de Vries, I Jolanda M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF NAVARRA   (Spain)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Bioluminescence; Cell tracking; Fluorescence; In vivo imaging; MRI; Multimodal; PET; SPECT

Indexed keywords

ANTIBODY; CHELATE; ENHANCED GREEN FLUORESCENT PROTEIN; GADOLINIUM; GOLD NANOPARTICLE; IRON OXIDE; LUCIFERASE; NANOPARTICLE; SILICON DIOXIDE; SUPERPARAMAGNETIC IRON OXIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TRACER;

ARTICLE; BIOLUMINESCENCE; CELL DIVISION; CELL LABELING; CELL POPULATION; CELL THERAPY; CELL TRACKING; CELL TYPE; CELL VIABILITY; COMPUTER ASSISTED TOMOGRAPHY; CYTOKINE RELEASE; EMULSION; FLOW CYTOMETRY; FLUORESCENCE IMAGING; HISTOLOGY; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; INSTRUMENT VALIDATION; LUMINESCENCE; MEDICAL LITERATURE; MESENCHYMAL STEM CELL; MICROSCOPY; MOLECULAR IMAGING; MULTIMODAL IMAGING; NEURAL STEM CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ISLET; PANCREAS ISLET CELL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REPORTER GENE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEM CELL; STROMA CELL; TUMOR CELL; TUMOR CELL LINE; ULTRASOUND; WHOLE BODY SCINTISCANNING;

BIOLUMINESCENCE; CELL TRACKING; FLUORESCENCE; IN VIVO IMAGING; MRI; MULTIMODAL; PET; SPECT;

ANIMALS; CELL TRACKING; CELL- AND TISSUE-BASED THERAPY; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 84890919211     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.1561     Document Type: Article

References (35)

1. Srinivas M, Aarntzen EH, Bulte JW, Oyen WJ, Heerschap A, de Vries IJ, Figdor CG. Imaging of cellular therapies. Adv Drug Deliv Rev 2010;62(11):1080-1093.
2. Cho JH, Hong KS, Cho J, Chang SK, Cheong C, Lee NH, Kim H, Warren WS, Ahn S, Lee C. Detection of iron-labeled single cells by MR imaging based on intermolecular double quantum coherences at 14T. J Magn Reson 2012;217:86-91.
3. Gilad AA, Winnard PT, Jr., van Zijl PC, Bulte JW. Developing MR reporter genes: promises and pitfalls. NMR Biomed 2007;20(3):275-290.
4. Srinivas M, Heerschap A, Ahrens ET, Figdor CG, de Vries IJ. (19)F MRI for quantitative in vivo cell tracking. Trends Biotechnol 2010; 28(7): 363-370.
5. Fontanellas A, Hervas-Stubbs S, Sampedro A, Collantes M, Azpilicueta A, Mauleon I, Paneda A, Quincoces G, Prieto J, Melero I, Penuelas I. PET imaging of thymidine kinase gene expression in the liver of non-human primates following systemic delivery of an adenoviral vector. Gene Ther 2009; 16(1): 136-141.
6. Niers JM, Chen JW, Lewandrowski G, Kerami M, Garanger E, Wojtkiewicz G, Waterman P, Keliher E, Weissleder R, Tannous BA. Single reporter for targeted multimodal in vivo imaging. J Am Chem Soc 2012; 134(11): 5149-5156.
7. Barnett BP, Ruiz-Cabello J, Hota P, Ouwerkerk R, Shamblott MJ, Lauzon C, Walczak P, Gilson WD, Chacko VP, Kraitchman DL, Arepally A, Bulte JW. Use of perfluorocarbon nanoparticles for non-invasive multimodal cell tracking of human pancreatic islets. Contrast Media Mol Imag 2011; 6(4): 251-259.
8. Arifin DR, Long CM, Gilad AA, Alric C, Roux S, Tillement O, Link TW, Arepally A, Bulte JW. Trimodal gadolinium-gold microcapsules containing pancreatic islet cells restore normoglycemia in diabetic mice and can be tracked by using US, CT, and positive-contrast MR imaging. Radiology 2011; 260(3): 790-798.
9. Jackson J, Chapon C, Jones W, Hirani E, Qassim A, Bhakoo K. In vivo multimodal imaging of stem cell transplantation in a rodent model of Parkinson's disease. J Neurosci Meth 2009; 183(2): 141-148.
10. Jo MH, Ali BA, Al-Khedhairy AA, Lee CH, Kim B, Haam S, Huh YM, Ko HY, Kim S. A reverse complementary multimodal imaging system to visualize microRNA9-involved neurogenesis using peptide targeting transferrin receptor-conjugated magnetic fluorescence nanoparticles. Biomaterials 2012; 33(27): 6456-6467.
11. De Vocht N, Reekmans K, Bergwerf I, Praet J, Hoornaert C, Le Blon D, Daans J, Berneman Z, Van der Linden A, Ponsaerts P. Multimodal imaging of stem cell implantation in the central nervous system of mice. J Vis Exp 2012; (64): e3906.
12. Misri R, Meier D, Yung AC, Kozlowski P, Hafeli UO. Development and evaluation of a dual-modality (MRI/SPECT) molecular imaging bioprobe. Nanomedicine 2012; 8(6): 1007-1016.
13. Huang X, Zhang F, Lee S, Swierczewska M, Kiesewetter DO, Lang L, Zhang G, Zhu L, Gao H, Choi HS, Niu G, Chen X. Long-term multimodal imaging of tumor draining sentinel lymph nodes using mesoporous silica-based nanoprobes. Biomaterials 2012; 33(17): 4370-4378.
14. Passuello T, Pedroni M, Piccinelli F, Polizzi S, Marzola P, Tambalo S, Conti G, Benati D, Vetrone F, Bettinelli M, Speghini A. PEG-capped, lanthanide doped GdF(3) nanoparticles: luminescent and T(2) contrast agents for optical and MRI multimodal imaging. Nanoscale, 2012 Dec 21; 4(24):7682-9. doi: 10.1039/c2nr31796f.Epub 2012 Nov 2.
15. Zhu X, Zhou J, Chen M, Shi M, Feng W, Li F. Core-shell Fe3O4 at NaLuF4:Yb, Er/Tm nanostructure for MRI, CT and upconversion luminescence tri-modality imaging. Biomaterials 2012; 33(18): 4618-4627.
16. Hwang do W, Ko HY, Kim SK, Kim D, Lee DS, Kim S. Development of a quadruple imaging modality by using nanoparticles. Chemistry 2009; 15(37): 9387-9393.
17. Azhdarinia A, Ghosh P, Ghosh S, Wilganowski N, Sevick-Muraca EM. Dual-labeling strategies for nuclear and fluorescence molecular imaging: a review and analysis. Mol Imag Biol 2012; 14(3): 261-276.
18. Guenoun J, Ruggiero A, Doeswijk G, Janssens RC, Koning GA, Kotek G, Krestin GP, Bernsen MR. In vivo quantitative assessment of cell viability of gadolinium or iron-labeled cells using MRI and bioluminescence imaging. Contrast Media Mol Imag 2013; 8(2): 165-174.
19. de Vries IJ, Lesterhuis WJ, Barentsz JO, Verdijk P, van Krieken JH, Boerman OC, Oyen WJ, Bonenkamp JJ, Boezeman JB, Adema GJ, Bulte JW, Scheenen TW, Punt CJ, Heerschap A, Figdor CG. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol 2005; 23(11): 1407-1413.
20. Aarntzen EH, Srinivas M, De Wilt JH, Jacobs JF, Lesterhuis WJ, Windhorst AD, Troost EG, Bonenkamp JJ, van Rossum MM, Blokx WA, Mus RD, Boerman OC, Punt CJ, Figdor CG, Oyen WJ, de Vries IJ. Early identification of antigen-specific immune responses in vivo by [18F]-labeled 3'-fluoro-3'-deoxy-thymidine ([18F]FLT) PET imaging. Proc Natl Acad Sci USA 2011; 108(45): 18396-18399.
21. Mant A, Chinnery F, Elliott T, Williams AP. The pathway of cross-presentation is influenced by the particle size of phagocytosed antigen. Immunology 2012; 136(2): 163-175.
22. Srinivas M, Turner MS, Janjic JM, Morel PA, Laidlaw DH, Ahrens ET. In vivo cytometry of antigen-specific t cells using (19)F MRI. Magn Reson Med 2009 Sep; 62(3): 747-53. doi: 10.1002/mrm.22063.
23. Laurent S, Burtea C, Thirifays C, Hafeli UO, Mahmoudi M. Crucial ignored parameters on nanotoxicology: the importance of toxicity assay modifications and 'cell vision'. PLoS One 2012; 7(1): e29997.
24. Mahmoudi M, Lynch I, Ejtehadi MR, Monopoli MP, Bombelli FB, Laurent S. Protein-nanoparticle interactions: opportunities and challenges. Chem Rev 2011; 111(9): 5610-5637.
25. Nejadnik H, Henning TD, Castaneda RT, Boddington S, Taubert S, Jha P, Tavri S, Golovko D, Ackerman L, Meier R, Daldrup-Link HE. Somatic differentiation and MR imaging of magnetically labeled human embryonic stem cells. Cell Transplant 2012; 21(12): 2555-67. doi: 10.3727/096368912X653156. Epub 2012 Aug 2.
26. Kim HS, Tian L, Lin S, Cha JH, Jung HS, Park KS, Moon WK. Magnetic labeling of pancreatic beta-cells modulates the glucose- and insulin-induced phosphorylation of ERK1/2 and AKT. Contrast Media Mol Imag 2013; 8(1): 20-26.
27. Li M, Kim HS, Tian L, Yu MK, Jon S, Moon WK. Comparison of two ultrasmall superparamagnetic iron oxides on cytotoxicity and mr imaging of tumors. Theranostics 2012; 2(1): 76-85.
28. Cromer Berman SM, Kshitiz, Wang CJ, Orukari I, Levchenko A, Bulte JW, Walczak P. Cell motility of neural stem cells is reduced after SPIO-labeling, which is mitigated after exocytosis. Magn Reson Med 2013 Jan; 69(1): 255-62. doi: 10.1002/mrm.24216. Epub 2012 Feb 28.
29. de Chickera SN, Snir J, Willert C, Rohani R, Foley R, Foster PJ, Dekaban GA. Labelling dendritic cells with SPIO has implications for their subsequent in vivo migration as assessed with cellular MRI. Contrast Media Mol Imag 2011; 6(4): 314-327.
30. Gholamrezanezhad A, Mirpour S, Ardekani JM, Bagheri M, Alimoghadam K, Yarmand S, Malekzadeh R. Cytotoxicity of 111In-oxine on mesenchymal stem cells: a time-dependent adverse effect. Nucl Med Commun 2009; 30(3): 210-216.
31. Nowak B, Weber C, Schober A, Zeiffer U, Liehn EA, von Hundelshausen P, Reinartz P, Schaefer WM, Buell U. Indium-111 oxine labelling affects the cellular integrity of haematopoietic progenitor cells. Eur J Nucl Med Mol Imag 2007; 34(5): 715-721.
32. Gupta A, Shamseddin MK, Khaira A. Pathomechanisms of nephrogenic systemic fibrosis: new insights. Clin Exp Dermatol 2011; 36(7): 763-768.
33. Longmire M, Choyke PL, Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine (Lond) 2008; 3(5): 703-717.
34. Vandsburger MH, Radoul M, Cohen B, Neeman M. MRI reporter genes: applications for imaging of cell survival, proliferation, migration and differentiation. NMR Biomed 2013 Jul; 26(7): 872-84. doi: 10.1002/nbm.2869. Epub 2012 Dec 6.
35. Mitra RN, Doshi M, Zhang X, Tyus JC, Bengtsson N, Fletcher S, Page BD, Turkson J, Gesquiere AJ, Gunning PT, Walter GA, Santra S. An activatable multimodal/multifunctional nanoprobe for direct imaging of intracellular drug delivery. Biomaterials 2012; 33(5): 1500-1508.